We are live on ! Find out more
DS

DRW Securities Portfolio holdings

AUM $7.21B
1-Year Est. Return 20.54%
This Fund
S&P 500
This Quarter Est. Return
+2.06%
1 Year Est. Return
+20.54%
3 Year Est. Return
+87.88%
5 Year Est. Return
+88.87%
10 Year Est. Return
+277.95%
AUM
$1.64B
AUM Growth
+$82.8M
Cap. Flow
+$66.1M
Cap. Flow %
4.04%
Top 10 Hldgs %
95.34%
Holding
198
New
36
Increased
37
Reduced
16
Closed
99

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$322M
2
GLD icon
SPDR Gold Trust
GLD
+$30.1M
3
FXI icon
iShares China Large-Cap ETF
FXI
+$17.9M
4
INDA icon
iShares MSCI India ETF
INDA
+$16.2M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$4.82M

Top Sells

Rank Stock Value
1
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$44.5M
2
BND icon
Vanguard Total Bond Market
BND
+$16.8M
3
EWT icon
iShares MSCI Taiwan ETF
EWT
+$10.2M
4
EZA icon
iShares MSCI South Africa ETF
EZA
+$6.8M
5
MCHI icon
iShares MSCI China ETF
MCHI
+$6.45M

Sector Composition

Rank Sector Weight
1 Healthcare 0.49%
2 Real Estate 0.02%
3 Financials 0.02%
4 Consumer Staples 0.01%
5 Consumer Discretionary 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRUS
51
DELISTED
Merus
MRUS
$286K 0.02%
+12,551
New +$234K
SPXU icon
52
ProShares UltraPro Short S&P 500
SPXU
$436M
$284K 0.02%
71
+12
+20% +$49.4K
AEL
53
CALL
DELISTED
American Equity Investment Life Holding Company
AEL
$284K 0.02%
+7,900
New +$255K
CTIC
54
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$277K 0.02%
55,561
+4,000
+8% +$17.5K
IMDZ
55
DELISTED
Immune Design Corp.
IMDZ
$268K 0.02%
58,900
+21,900
+59% +$87.2K
ZGNX
56
DELISTED
Zogenix, Inc.
ZGNX
$265K 0.02%
+6,000
New +$247K
BLPH
57
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$254K 0.02%
7,000
+2,333
+50% +$80.7K
AMRN
58
Amarin Corp
AMRN
$284M
$248K 0.02%
4,020
– –
ONCS
59
DELISTED
OncoSec Medical Incorporated
ONCS
$248K 0.02%
818
+500
+157% +$175K
OCGN icon
60
Ocugen
OCGN
$410M
$242K 0.01%
+1,615
New +$251K
CBAY
61
DELISTED
Cymabay Therapeutics
CBAY
$240K 0.01%
17,900
+900
+5% +$11.3K
FIZZ icon
62
National Beverage
FIZZ
$2.87B
$235K 0.01%
+4,392
New +$206K
EIGR
63
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$233K 0.01%
637
+104
+20% +$37K
BBBY
64
DELISTED
Bed Bath & Beyond Inc
BBBY
$229K 0.01%
+11,502
New +$215K
PVLA
65
Palvella Therapeutics
PVLA
$1.98B
$228K 0.01%
563
+188
+50% +$89.5K
CYTK icon
66
Cytokinetics
CYTK
$11B
$222K 0.01%
26,797
+12,797
+91% +$106K
SYBX
67
DELISTED
Synlogic
SYBX
$216K 0.01%
1,467
+200
+16% +$32.1K
ADVM
68
DELISTED
Adverum Biotechnologies
ADVM
$212K 0.01%
4,000
+1,500
+60% +$90.2K
GNCA
69
DELISTED
Genocea Biosciences, Inc.
GNCA
$205K 0.01%
+30,000
New +$224K
CVE icon
70
CALL
Cenovus Energy
CVE
$54.6B
$200K 0.01%
19,300
-4,000
-17% -$40.3K
RNAC icon
71
Cartesian Therapeutics
RNAC
$232M
$199K 0.01%
500
+100
+25% +$35.5K
AFMD
72
DELISTED
Affimed
AFMD
$198K 0.01%
12,000
+1,000
+9% +$21.1K
ALPN
73
DELISTED
Alpine Immune Sciences Inc
ALPN
$184K 0.01%
24,343
+14,143
+139% +$117K
TARA icon
74
Protara Therapeutics
TARA
$226M
$181K 0.01%
1,842
+500
+37% +$46.6K
CFRX
75
DELISTED
ContraFect Corporation
CFRX
$177K 0.01%
100
-38
-28% -$56K
1 2
3
4 5

Similar funds

CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return
UB
UMB Bank Kansas City, Missouri $7.16B AUM 20.88% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
FPA
First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $7.13B AUM 35.47% 1-Year Est. Return
GLF
Groupe la Francaise Paris, France $7.29B AUM 37.28% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

DRW Securities's Q2 2018 Portfolio in Review

As of Q2 2018, DRW Securities held 198 positions worth $1.64B, up 5.3% from $1.55B the previous quarter. Its ten largest holdings account for 95% of the portfolio.

DRW Securities deployed $66.1M of net new capital in Q2 2018, opening 36 new positions and adding to 37 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 40,335 shares worth $4.91M.

By sector, the portfolio is most concentrated in Healthcare at 0.49% of assets, down from 0.51% a quarter earlier, followed by Real Estate and Financials.

On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $44.5M trimmed.

  • DRW Securities's largest Q2 2018 buy was iShares 20+ Year Treasury Bond ETF: 40,335 shares worth $4.91M.
  • DRW Securities added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $322M increase.
  • DRW Securities's biggest Q2 2018 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $44.5M.
  • DRW Securities fully exited Vanguard Total Bond Market in Q2 2018, selling an estimated $16.8M.
  • DRW Securities's ten largest holdings make up 95% of its $1.64B portfolio in Q2 2018.
  • DRW Securities opened 36 new positions and closed 99 in Q2 2018.
  • DRW Securities's portfolio value rose 5.3% quarter-over-quarter to $1.64B.

Based on DRW Securities's 13F filing for Q2 2018, filed 14 Aug 2018.